Crypto emerges as key 2026 election issue
Cryptocurrency is becoming a more prominent issue in the 2026 US midterm elections after a new DCG-Harris Poll found that 40% of registered voters now view digital asset policy as a major election issue.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Cryptocurrency is becoming a more prominent issue in the 2026 US midterm elections after a new DCG-Harris Poll found that 40% of registered voters now view digital asset policy as a major election issue.
Strata Investment (ASX:SRT) received unsolicited, confidential, non-binding and indicative proposal from Ontario-based Freedom BidCo.
Bitcoin traded near $61,750 as analysts warned that SpaceX's anticipated public offering could draw capital away from cryptocurrencies at a time when market sentiment and institutional demand are already weakening.
POSCO Holdings and Anson Resources (ASX:ASN) partner to build a fully funded DLE lithium demonstration plant at the Green River Project.
Medicus Pharma (NASDAQ:MDCX) submitted an Investigational New Drug (IND) application to the Department of Health, Abu Dhabi, seeking authorization to launch a genomics-enabled Phase 2a clinical trial evaluating its candidate Teverelix in women with symptomatic endometriosis.
Trad.Fi plans to bring up to $650 million in equipment-finance private credit onchain over the next 48 months as it targets one of the largest and least digitised lending markets in the United States.
An AI-generated campaign advertisement in Minnesota has intensified concerns about the use of deepfakes in political campaigns as election spending reaches record levels across the United States.
Bitcoin traders are closely watching the Bank of Japan’s June 16 policy meeting after BTC suffered declines of between 18% and 28% following each of the central bank’s four rate hikes since 2024.
Motorists are warned to brace for impact as the Albanese government signals the temporary fuel tax cut will likely end in June.
Nexalin Technology (NASDAQ:NXL) reported the successful completion of an 8-week, single-center, prospective, open-label clinical trial evaluating its proprietary 15 milliamp (mA), 77.5 Hz Deep Intracranial Frequency Stimulation (DIFS™) protocol in adults with generalized anxiety disorder and comorbid insomnia.